A growing concern in healthcare is the spread of antibiotic-resistant bacteria, especially among vulnerable populations like newborns in low- and middle-income countries (LMICs). A recent study published in
JAMA Network Open
sheds light on the alarming prevalence of antibiotic resistance in infants younger than 3 months in these settings.
Antibiotic-Resistant Bacteria Colonize Newborns in LMICs
The study, conducted by a team of French researchers, analyzed 67 studies involving over 17,000 infants. This comprehensive review revealed a “substantial” proportion of infants colonized with resistant bacteria. The meta-analysis found a pooled prevalence of 30.2% for 3GCRE colonization, ranging from 18.2% in non-hospitalized infants to 48.2% in hospitalized infants. The prevalence of CRE and MRSA colonization was 2.6% and 2.7%, respectively.
Risk Factors for Antibiotic Resistance in Newborns
The study also identified key risk factors for antibiotic-resistant bacteria colonization in newborns. These factors include:
- Hospital birth
- Neonatal antibiotic use
- Prolonged rupture of membranes
These findings highlight the critical need to strengthen infection control and antimicrobial stewardship practices in maternity and neonatal units in LMICs.
Understanding the Neonatal Microbiome
The researchers suggest that the neonatal microbiome, being relatively undeveloped at birth, may play a role in the high prevalence of antibiotic resistance. The limited diversity of bacteria in a newborn’s gut can make them more susceptible to colonization by resistant pathogens even after brief exposure.
“This limited diversity may facilitate the establishment of antibiotic-resistant pathogens in neonates even after brief exposure,” the authors wrote. “Additionally, it may lead to faster bacterial selection following antibiotic administration, potentially increasing the effect of antibiotic administration on the acquisition of antibiotic-resistant pathogens in neonates compared with adults or children.”
Call to Action
This study underscores the urgent need for interventions to prevent neonatal colonization with antibiotic-resistant bacteria. Healthcare professionals, policymakers, and researchers must work together to address this growing threat and protect the health of newborns in LMICs.